Annual EBIT
-$7.26 M
+$1.47 M+16.82%
December 31, 2023
Summary
- As of February 7, 2025, ZIVO annual earnings before interest & taxes is -$7.26 million, with the most recent change of +$1.47 million (+16.82%) on December 31, 2023.
- During the last 3 years, ZIVO annual EBIT has risen by +$1.29 million (+15.11%).
- ZIVO annual EBIT is now -707.07% below its all-time high of $1.20 million, reached on December 31, 2014.
Performance
ZIVO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$2.26 M
+$5.97 M+72.54%
September 30, 2024
Summary
- As of February 7, 2025, ZIVO quarterly earnings before interest & taxes is -$2.26 million, with the most recent change of +$5.97 million (+72.54%) on September 30, 2024.
- Over the past year, ZIVO quarterly EBIT has dropped by -$363.40 thousand (-19.16%).
- ZIVO quarterly EBIT is now -155.09% below its all-time high of $4.10 million, reached on March 31, 2014.
Performance
ZIVO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$13.66 M
-$687.60 K-5.30%
September 30, 2024
Summary
- As of February 7, 2025, ZIVO TTM earnings before interest & taxes is -$13.66 million, with the most recent change of -$687.60 thousand (-5.30%) on September 30, 2024.
- Over the past year, ZIVO TTM EBIT has dropped by -$6.40 million (-88.10%).
- ZIVO TTM EBIT is now -1241.93% below its all-time high of $1.20 million, reached on December 31, 2014.
Performance
ZIVO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ZIVO EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.8% | -19.2% | -88.1% |
| 3 y3 years | +15.1% | +14.3% | -56.5% |
| 5 y5 years | -11.1% | +14.3% | -56.5% |
ZIVO EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +16.8% | -77.1% | +72.5% | -108.0% | at low |
| 5 y | 5-year | at high | +16.8% | -119.4% | +72.5% | -108.0% | at low |
| alltime | all time | -707.1% | +24.8% | -155.1% | +72.5% | -1241.9% | at low |
ZIVO Bioscience EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.26 M(-72.5%) | -$13.66 M(+5.3%) |
| Jun 2024 | - | -$8.23 M(+545.1%) | -$12.97 M(+97.5%) |
| Mar 2024 | - | -$1.28 M(-32.7%) | -$6.57 M(-9.6%) |
| Dec 2023 | -$7.26 M(-16.8%) | -$1.90 M(+20.6%) | -$7.26 M(-9.3%) |
| Sep 2023 | - | -$1.57 M(-13.8%) | -$8.00 M(-5.1%) |
| Jun 2023 | - | -$1.82 M(-7.4%) | -$8.43 M(-2.8%) |
| Mar 2023 | - | -$1.97 M(-25.3%) | -$8.68 M(-0.6%) |
| Dec 2022 | -$8.73 M(+2.5%) | -$2.64 M(+31.9%) | -$8.73 M(-6.7%) |
| Sep 2022 | - | -$2.00 M(-3.3%) | -$9.36 M(+5.0%) |
| Jun 2022 | - | -$2.07 M(+2.0%) | -$8.91 M(+3.7%) |
| Mar 2022 | - | -$2.03 M(-37.9%) | -$8.59 M(-0.7%) |
| Dec 2021 | -$8.52 M(-0.4%) | -$3.26 M(+110.4%) | -$8.65 M(+21.1%) |
| Sep 2021 | - | -$1.55 M(-11.3%) | -$7.14 M(-20.3%) |
| Jun 2021 | - | -$1.75 M(-16.0%) | -$8.95 M(+8.7%) |
| Mar 2021 | - | -$2.08 M(+18.7%) | -$8.23 M(-3.8%) |
| Dec 2020 | -$8.56 M(+2.4%) | -$1.75 M(-47.8%) | -$8.56 M(-19.1%) |
| Sep 2020 | - | -$3.36 M(+226.7%) | -$10.57 M(+20.4%) |
| Jun 2020 | - | -$1.03 M(-57.2%) | -$8.78 M(-10.3%) |
| Mar 2020 | - | -$2.41 M(-36.2%) | -$9.79 M(+17.2%) |
| Dec 2019 | -$8.35 M(+27.7%) | -$3.77 M(+139.7%) | -$8.35 M(+34.5%) |
| Sep 2019 | - | -$1.57 M(-22.7%) | -$6.21 M(+1.1%) |
| Jun 2019 | - | -$2.04 M(+110.5%) | -$6.14 M(+11.1%) |
| Mar 2019 | - | -$967.90 K(-40.6%) | -$5.53 M(-15.4%) |
| Dec 2018 | -$6.54 M(-7.8%) | -$1.63 M(+8.1%) | -$6.54 M(-13.4%) |
| Sep 2018 | - | -$1.51 M(+5.8%) | -$7.55 M(-9.3%) |
| Jun 2018 | - | -$1.43 M(-27.8%) | -$8.32 M(+7.0%) |
| Mar 2018 | - | -$1.97 M(-25.3%) | -$7.78 M(+9.3%) |
| Dec 2017 | -$7.09 M(+41.7%) | -$2.64 M(+16.0%) | -$7.12 M(+33.0%) |
| Sep 2017 | - | -$2.28 M(+158.5%) | -$5.35 M(+34.9%) |
| Jun 2017 | - | -$881.40 K(-33.0%) | -$3.97 M(-22.9%) |
| Mar 2017 | - | -$1.32 M(+50.2%) | -$5.14 M(+2.9%) |
| Dec 2016 | -$5.00 M(-1.3%) | -$876.30 K(-1.9%) | -$5.00 M(+1.4%) |
| Sep 2016 | - | -$892.90 K(-56.7%) | -$4.93 M(-7.4%) |
| Jun 2016 | - | -$2.06 M(+75.7%) | -$5.32 M(+4.3%) |
| Mar 2016 | - | -$1.17 M(+45.6%) | -$5.11 M(+0.7%) |
| Dec 2015 | -$5.07 M(-523.6%) | -$805.50 K(-37.4%) | -$5.07 M(+48.9%) |
| Sep 2015 | - | -$1.29 M(-30.1%) | -$3.40 M(-35.9%) |
| Jun 2015 | - | -$1.84 M(+62.2%) | -$5.31 M(+31.4%) |
| Mar 2015 | - | -$1.14 M(-232.2%) | -$4.04 M(-437.7%) |
| Dec 2014 | $1.20 M(-112.4%) | $858.30 K(-126.9%) | $1.20 M(+42.3%) |
| Sep 2014 | - | -$3.19 M(+458.4%) | $840.80 K(-251.9%) |
| Jun 2014 | - | -$571.70 K(-113.9%) | -$553.70 K(-74.0%) |
| Mar 2014 | - | $4.10 M(+716.0%) | -$2.13 M(-69.9%) |
| Dec 2013 | -$9.65 M(+327.9%) | $502.70 K(-111.0%) | -$7.08 M(-6.6%) |
| Sep 2013 | - | -$4.59 M(+113.4%) | -$7.58 M(+115.5%) |
| Jun 2013 | - | -$2.15 M(+153.3%) | -$3.52 M(+128.8%) |
| Mar 2013 | - | -$848.60 K(<-9900.0%) | -$1.54 M(+7.9%) |
| Dec 2012 | -$2.26 M | $2800.00(-100.5%) | -$1.43 M(-44.1%) |
| Sep 2012 | - | -$523.70 K(+210.1%) | -$2.55 M(+10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | -$168.90 K(-77.0%) | -$2.31 M(-3.9%) |
| Mar 2012 | - | -$735.70 K(-34.5%) | -$2.41 M(+14.7%) |
| Dec 2011 | -$2.10 M(-48.3%) | -$1.12 M(+294.6%) | -$2.10 M(+23.2%) |
| Sep 2011 | - | -$284.80 K(+8.0%) | -$1.70 M(-13.6%) |
| Jun 2011 | - | -$263.80 K(-38.4%) | -$1.97 M(-44.1%) |
| Mar 2011 | - | -$427.90 K(-41.2%) | -$3.53 M(-13.2%) |
| Dec 2010 | -$4.06 M(+53.1%) | -$727.80 K(+31.7%) | -$4.06 M(-2.4%) |
| Sep 2010 | - | -$552.80 K(-69.6%) | -$4.16 M(-9.4%) |
| Jun 2010 | - | -$1.82 M(+88.8%) | -$4.59 M(+48.7%) |
| Mar 2010 | - | -$962.90 K(+16.3%) | -$3.09 M(+16.4%) |
| Dec 2009 | -$2.65 M(+119.3%) | -$827.70 K(-15.8%) | -$2.65 M(+29.6%) |
| Sep 2009 | - | -$982.60 K(+213.0%) | -$2.05 M(+55.5%) |
| Jun 2009 | - | -$313.90 K(-40.7%) | -$1.32 M(-9.8%) |
| Mar 2009 | - | -$529.00 K(+138.7%) | -$1.46 M(+20.7%) |
| Dec 2008 | -$1.21 M(-45.8%) | -$221.60 K(-12.2%) | -$1.21 M(-15.1%) |
| Sep 2008 | - | -$252.30 K(-44.9%) | -$1.43 M(-23.6%) |
| Jun 2008 | - | -$457.60 K(+64.3%) | -$1.86 M(-0.4%) |
| Mar 2008 | - | -$278.50 K(-36.2%) | -$1.87 M(-16.2%) |
| Dec 2007 | -$2.23 M(-41.8%) | -$436.60 K(-36.9%) | -$2.23 M(-21.7%) |
| Sep 2007 | - | -$692.10 K(+48.8%) | -$2.85 M(+1.7%) |
| Jun 2007 | - | -$465.00 K(-27.5%) | -$2.80 M(-20.5%) |
| Mar 2007 | - | -$641.00 K(-39.2%) | -$3.53 M(-8.1%) |
| Dec 2006 | -$3.84 M(+20.7%) | -$1.05 M(+63.6%) | -$3.84 M(+2.5%) |
| Sep 2006 | - | -$644.40 K(-45.8%) | -$3.75 M(-20.5%) |
| Jun 2006 | - | -$1.19 M(+25.2%) | -$4.71 M(+21.8%) |
| Mar 2006 | - | -$950.40 K(-1.3%) | -$3.87 M(+18.6%) |
| Dec 2005 | -$3.18 M(-17.6%) | -$962.60 K(-40.3%) | -$3.26 M(+14.3%) |
| Sep 2005 | - | -$1.61 M(+364.8%) | -$2.86 M(+30.1%) |
| Jun 2005 | - | -$346.70 K(+0.9%) | -$2.20 M(-15.2%) |
| Mar 2005 | - | -$343.50 K(-38.1%) | -$2.59 M(-32.9%) |
| Dec 2004 | -$3.86 M(+613.3%) | -$555.20 K(-41.6%) | -$3.86 M(+0.5%) |
| Sep 2004 | - | -$950.30 K(+28.6%) | -$3.84 M(+32.9%) |
| Jun 2004 | - | -$739.10 K(-54.2%) | -$2.89 M(+34.3%) |
| Mar 2004 | - | -$1.61 M(+199.9%) | -$2.15 M(+297.9%) |
| Dec 2003 | -$540.80 K(>+9900.0%) | -$537.80 K(>+9900.0%) | -$540.90 K(>+9900.0%) |
| Sep 2003 | - | -$600.00(0.0%) | -$3700.00(0.0%) |
| Jun 2003 | - | -$600.00(-68.4%) | -$3700.00(0.0%) |
| Mar 2003 | - | -$1900.00(+216.7%) | -$3700.00(+8.8%) |
| Dec 2002 | -$3400.00(+61.9%) | -$600.00(0.0%) | -$3400.00(0.0%) |
| Sep 2002 | - | -$600.00(0.0%) | -$3400.00(0.0%) |
| Jun 2002 | - | -$600.00(-62.5%) | -$3400.00(0.0%) |
| Mar 2002 | - | -$1600.00(+166.7%) | -$3400.00(+70.0%) |
| Dec 2001 | -$2100.00(-41.7%) | -$600.00(0.0%) | -$2000.00(-54.5%) |
| Sep 2001 | - | -$600.00(0.0%) | -$4400.00(0.0%) |
| Jun 2001 | - | -$600.00(+200.0%) | -$4400.00(+15.8%) |
| Mar 2001 | - | -$200.00(-93.3%) | -$3800.00(+5.6%) |
| Dec 2000 | -$3600.00 | -$3000.00(+400.0%) | -$3600.00(+500.0%) |
| Sep 2000 | - | -$600.00(-96.1%) | -$600.00(-96.1%) |
| Sep 1999 | - | -$15.20 K | -$15.20 K |
FAQ
- What is ZIVO Bioscience annual earnings before interest & taxes?
- What is the all time high annual EBIT for ZIVO Bioscience?
- What is ZIVO Bioscience annual EBIT year-on-year change?
- What is ZIVO Bioscience quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly EBIT year-on-year change?
- What is ZIVO Bioscience TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ZIVO Bioscience?
- What is ZIVO Bioscience TTM EBIT year-on-year change?
What is ZIVO Bioscience annual earnings before interest & taxes?
The current annual EBIT of ZIVO is -$7.26 M
What is the all time high annual EBIT for ZIVO Bioscience?
ZIVO Bioscience all-time high annual earnings before interest & taxes is $1.20 M
What is ZIVO Bioscience annual EBIT year-on-year change?
Over the past year, ZIVO annual earnings before interest & taxes has changed by +$1.47 M (+16.82%)
What is ZIVO Bioscience quarterly earnings before interest & taxes?
The current quarterly EBIT of ZIVO is -$2.26 M
What is the all time high quarterly EBIT for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly earnings before interest & taxes is $4.10 M
What is ZIVO Bioscience quarterly EBIT year-on-year change?
Over the past year, ZIVO quarterly earnings before interest & taxes has changed by -$363.40 K (-19.16%)
What is ZIVO Bioscience TTM earnings before interest & taxes?
The current TTM EBIT of ZIVO is -$13.66 M
What is the all time high TTM EBIT for ZIVO Bioscience?
ZIVO Bioscience all-time high TTM earnings before interest & taxes is $1.20 M
What is ZIVO Bioscience TTM EBIT year-on-year change?
Over the past year, ZIVO TTM earnings before interest & taxes has changed by -$6.40 M (-88.10%)